Sequential Prostate Artery Embolization and Radiation Therapy Evaluation: SPARE

Clinical Trial Details

The purpose of this study is to learn more about the outcomes of prostate artery embolization (PAE) and evaluate the safety of PAE prior to radiation therapy for prostate cancer.

Study participation also includes study visits, surveys, and sample collection.

Key Eligibility: 
  1. Open to men at the age of 18 and over
  2. Participants must have a confirmed diagnosis of prostate cancer who are also planning to receive radiation therapy

Detailed eligibility will be reviewed when contacting the study team.

Study contact by location

Upper East Side - Manhattan

Contact(s)

Sarah Cha
646-581-0756
sac9119@nyp.org

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

2605030253

Status

Open to Enrollment

Age Group

Adult

Sponsor

Disease